Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
(11 sites) United States
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California Los Angeles General Medical Center, Los Angeles, California USC / Norris Comprehensive Cancer Center, Los Angeles, California UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California University of Michigan Rogel Cancer Center, Ann Arbor, Michigan University of Michigan - Brighton Center for Specialty Care, Brighton, Michigan UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina Ohio State University Comprehensive Cancer Center, Columbus, Ohio University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin Canada
University Health Network-Princess Margaret Hospital, Toronto, Ontario